Delta-8 Gummies Look Like Candy, and Poison Centers Keep Seeing Small Children Who Ate Them
#57 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Clinicians need to recognize that delta-8 THC products sold as unregulated gummies pose a serious poisoning risk to young children who may mistake them for candy, requiring awareness of this presentation pattern for accurate diagnosis and rapid management of pediatric toxicity cases. Since delta-8 products lack FDA oversight and standardized labeling, pediatricians should counsel parents on safe storage and educate them that these products are not child-resistant despite being marketed as food items. This case highlights a gap between current poison prevention messaging, which typically focuses on traditional cannabis products, and the emerging threat of accessible delta-8 formulations that demand updated clinical protocols for pediatric exposure management.
Delta-8 tetrahydrocannabinol products, marketed as legal hemp-derived alternatives to delta-9 THC, are increasingly sold as retail gummies that are indistinguishable from conventional candy, creating significant pediatric poisoning risks. A case report documents two young sisters (ages 2 and 4) who required pediatric intensive care unit admission after accidental ingestion of delta-8 gummies, presenting with altered mental status, seizure activity, and hemodynamic instability. The cases highlight that delta-8 products lack uniform dosing standards, child-resistant packaging requirements, and clear labeling in many jurisdictions, and that poison center calls involving pediatric delta-8 exposure have increased substantially as these products proliferate in convenience stores and online retailers. Clinicians managing pediatric toxicology cases should recognize delta-8 THC as a potential culprit in unexplained altered mental status, seizures, or sympathomimetic symptoms in young children with access to retail candy-like products. The clinical takeaway for practitioners is to counsel families to store all cannabis products securely out of children’s reach and to consider delta-8 exposure in the differential diagnosis of acute neurological symptoms in toddlers and young children, while advocating for regulatory standards that mandate child-resistant packaging and accurate labeling for all hemp-derived cannabinoid products.
“What we’re seeing with delta-8 products marketed as gummies is a real packaging and labeling problem that poison centers are documenting, but the case reports we have so far, while concerning, represent a small number of exposures – we need systematic surveillance data to understand the true incidence and whether this is a widespread risk or a cluster phenomenon, and regardless, the fundamental issue here is that these products are accessible to children in ways they shouldn’t be.”
🍬 The rising prevalence of delta-8 tetrahydrocannabinol products marketed as consumer goods presents a genuine pediatric poisoning risk that clinicians should recognize, particularly given their candy-like appearance and accessibility in retail settings. While delta-8 is a minor cannabinoid with lower potency than delta-9 THC, case reports of severe toxicity in young children—including altered mental status, respiratory depression, and seizure activity—indicate that accidental pediatric ingestion can produce significant clinical consequences requiring intensive care management. Poison center data and emergency department encounters will likely continue rising as delta-8 products proliferate in an unregulated market; practitioners should maintain a low threshold for suspecting cannabinoid exposure in young children presenting with unexplained altered consciousness, ataxia, or autonomic instability. It is important to acknowledge that long-term developmental outcomes following pediatric delta-8 exposure remain unknown
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
